Longevity Health Holdings, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Market information for Common Stock
Beginning on March 10, 2025, our Common Stock trades on the Nasdaq Capital Market under the symbol “XAGE”.
On March 27, 2025, the closing price for our Common Stock as reported by the Nasdaq Capital Market was $0.1542.
Holders of record
As of March 27, 2025, the approximate number of holders of record of our Common Stock was 218. This number does not include beneficial owners whose shares are held by nominees in street name.
Dividends
We have never declared or paid cash dividends on our capital stock. We intend to retain all available funds and future earnings, if any, to fund the development and expansion of our business, and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination related to dividend policy will be made at the discretion of our board of directors and will depend on a number of factors, including future earnings, capital requirements, financial conditions, future prospects, contractual restrictions and covenants, and other factors that our board of directors may deem relevant.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.